September 4, 2013—Eli Lilly & Co. is the second known drug manufacturer to obtain federal approval to conduct its own audits of 340B covered entities, it has emerged.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)